Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. Ricci
Observed names:
A. RICCI,
A.Ricci Aricci,
Ricci A,
Ricci A.,
Ricci, A.
Institutions:
Ghent University,
University of Turin
Observed institutions:
Ghent University,
University of Turin
OpenAlex ID:
A5154989495
Interferon-beta-1b in multiple sclerosis: comparing two different doses (the OPTIMS Study)
2004
·
DURELLI, Luca
, CLERICO, Marinella
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
·
2
High-dose (375 mcg) interferon beta-1b treatment of multiple sclerosis and neutralising antibodies. Long-term follow-up
2006
·
DURELLI, Luca
, CUCCI, Marie Angele
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
·
1
Aromi e identità sensoriale dei vini bianchi italiani: le ruote sensoriali varietali per riconoscere il vitigno nel bicchiere
2026
·
Piombino P.
, Pittari E.
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
PDF
Intensificazione sostenibile nella filiera vite-vino
2022
·
Failla, O.
, Gerbi, Vincenzo
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
The aroma diversity of Italian white wines: a further piece added to the D-Wines project
2022
·
Piombino P.
, Pittari E.
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Evaluation of oxidative stress and peripheral concentrations of inflammatory cytokines in dairy cows with postpartum metritis
2022
·
S. Malledevarahalli Chandrappa
, O. Bogado Pascottini
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
PDF
Use of Steroids After Liver Transplantation Is Associated With Lower Risk of Early Graft Failure (egf): Insights From the Liver Match Cohort Study
2010
·
Angelico M
, Marianelli T
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
A 4-year multicenter follow-up of neutralizing anti-interferon antibodies in ms patients treated with high dose (375 mcg) interferon beta-1b
2006
·
A. TAVELLA
, A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Comparision of a biological (mxa protein level) and an mri treatment response indicator for interferon beta therapy in multiple sclerosis
2006
·
G. CONTESSA
, CLERICO, Marinella
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Treatment response indicators in multiple sclerosis. Persistence of mri activity during first months of immune-modulating drug treatment is predictive of persistence of clinical disease activity over the long term
2005
·
DURELLI, Luca
, VERSINO, Elisabetta
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Looking for treatment response indicator. real- time rt-pcr determination of mrna levels of cytokine, chemokine and chemokine receptors in Multiple Sclerosis patients treated with ifn beta 1b: correlation with mri response
2005
·
CUCCI, Marie Angele
, A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Risk of cancers in patients with myasthenia gravis treated with immuno-suppressive treatments: the experience of torino university centre
2005
·
A. PIPIERI
, B. FERRERO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Long-term predictivity analysis trial of a treatment response marker to immunomodulatory drug in MS and evaluation of high-dose interferon beta treatment
2005
·
DURELLI, Luca
, CLERICO, Marinella
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Interferon beta-1b 500 mcg every-other-day in ms patients. Clinical and mri results
2005
·
P. BARBERO
, A. PIPIERI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
IFN beta-1b 500 mcg every-other-day, subcutaneously in MS patients. Tolerability, clinical and MRI results after one year of treatment
2005
·
CLERICO, Marinella
, A. Pipaeri
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Ischaemic stroke due to post-chemiotherapy embolism: case report
2005
·
B. FERRERO
, E. VERDUN
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Autoimmunity profile in interferon beta- 1a treated Multiple Sclerosis patients. the auprin study: comparison of 2 different dosage of subcutaneous interferon-beta 1a
2005
·
E. VERDUN
, L. GIORDANO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Real-time rt-pcr determination of mrna levels of cytokine, chemokine and chemokine receptors, in patients treated with ifn beta 1b: correlation with mri response and evaluation of a prognostic marker in ms.
2005
·
CUCCI, Marie Angele
, A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Mxa protein in ms patients treated with different doses of ifn beta-1b (the optims study): correlation with treatment response, ifn beta dose, and neutralizing antibodies (nab)occurrence
2005
·
A. RICCI
, L. GIORDANO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
IFN beta-1b in multiple sclerosis: comparing two different doses (the Optims Study).
2004
·
E. VERDUN
, P. BARBERO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Mxa protein, interleukin-10 (il-10) and neutralizing antibody (nab) in relapsing- remitting (rr) multiple sclerosis (ms) patients treated with different doses of inteferon (ifn) beta- 1b.
2004
·
A. RICCI
, CUCCI, Marie Angele
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Mxa protein and interleukin-10 (il-10) leukocyte production and anti-ifn neutralizing antibody(nab) occurrence in relapsing remitting multiple sclerosis (rrms) patients treated with different doses of interferon (ifn) beta- 1b
2004
·
CLERICO, Marinella
, A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Autoimmunity profile in interferon beta- 1a treated multiple sclerosis patients. the auprin study: comparision of 2 different dosage of subcutaneous interferon-beta 1a.
2004
·
E. VERDUN
, A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Every-other-day interferon beta-1b compared with once-weekly interferon beta-1a in MS. Further analysis of treatment effect on MR1 activity and neutralising antibodies (NAbs) in the INCOMIN Trial
2004
·
P. Barbero
, A. Ricci
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Every-other-day interferon beta-1b compared with once weekly interferon beta 1-a in ms. further analysis of treatment effect on mri activity and neutralizing antibodies (nabs) in the INCOMIN trial
2004
·
P. BARBERO
, M. BERGUI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Show more works
View as search
Works count:
39
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type